These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 9560145)

  • 21. Parkin and Parkinson's: more than homonymy?
    Corti O; Brice A
    Ann Neurol; 2001 Sep; 50(3):283-5. PubMed ID: 11558783
    [No Abstract]   [Full Text] [Related]  

  • 22. Cloning of rat parkin cDNA and distribution of parkin in rat brain.
    Gu WJ; Abbas N; Lagunes MZ; Parent A; Pradier L; Bohme GA; Agid Y; Hirsch EC; Raisman-Vozari R; Brice A
    J Neurochem; 2000 Apr; 74(4):1773-6. PubMed ID: 10737637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The parkin gene is not involved in late-onset Parkinson's disease.
    Kann M; Hedrich K; Vieregge P; Jacobs H; Müller B; Kock N; Schwinger E; Klein C; Marder K; Harris J; Meija-Santana H; Bressman S; Ozelius LJ; Lang AE; Pramstaller PP
    Neurology; 2002 Mar; 58(5):835; author reply 835. PubMed ID: 11889262
    [No Abstract]   [Full Text] [Related]  

  • 24. Parkin western blotting is useful for identification of patients with Parkin-related Parkinson's disease.
    Koentjoro B; Park JS; Sue CM
    J Neurol Neurosurg Psychiatry; 2014 Dec; 85(12):1436-7. PubMed ID: 24816420
    [No Abstract]   [Full Text] [Related]  

  • 25. Polymorphism in the parkin gene in sporadic Parkinson's disease.
    Wang M; Hattori N; Matsumine H; Kobayashi T; Yoshino H; Morioka A; Kitada T; Asakawa S; Minoshima S; Shimizu N; Mizuno Y
    Ann Neurol; 1999 May; 45(5):655-8. PubMed ID: 10319889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Linkage stratification and mutation analysis at the Parkin locus identifies mutation positive Parkinson's disease families.
    Nichols WC; Pankratz N; Uniacke SK; Pauciulo MW; Halter C; Rudolph A; Conneally PM; Foroud T
    J Med Genet; 2002 Jul; 39(7):489-92. PubMed ID: 12114481
    [No Abstract]   [Full Text] [Related]  

  • 27. NMR structure of ubiquitin-like domain in PARKIN: gene product of familial Parkinson's disease.
    Tashiro M; Okubo S; Shimotakahara S; Hatanaka H; Yasuda H; Kainosho M; Yokoyama S; Shindo H
    J Biomol NMR; 2003 Feb; 25(2):153-6. PubMed ID: 12652124
    [No Abstract]   [Full Text] [Related]  

  • 28. Lewy bodies in the cerebellar dentate nucleus of a patient with Parkinson's disease.
    Kakita A; Takahashi H; Homma Y; Ikuta F
    Pathol Int; 1994 Dec; 44(12):878-80. PubMed ID: 7866573
    [No Abstract]   [Full Text] [Related]  

  • 29. Camptocormia, axial dystonia, and parkinsonism: phenotypic heterogeneity of a parkin mutation.
    Inzelberg R; Hattori N; Nisipeanu P; Abo Mouch S; Blumen SC; Carasso RL; Mizuno Y
    Neurology; 2003 Apr; 60(8):1393-4. PubMed ID: 12707457
    [No Abstract]   [Full Text] [Related]  

  • 30. A novel transactivation domain in parkin.
    Morett E; Bork P
    Trends Biochem Sci; 1999 Jun; 24(6):229-31. PubMed ID: 10366851
    [No Abstract]   [Full Text] [Related]  

  • 31. No differential DNA methylation of PARK2 in brain of Parkinson's disease patients and healthy controls.
    De Mena L; Cardo LF; Coto E; Alvarez V; Coto E
    Mov Disord; 2013 Dec; 28(14):2032-3. PubMed ID: 23868535
    [No Abstract]   [Full Text] [Related]  

  • 32. Protein degradation: Parkin finds a partner and a victim.
    Brooksbank C
    Nat Rev Mol Cell Biol; 2001 Jan; 2(1):4-5. PubMed ID: 11413449
    [No Abstract]   [Full Text] [Related]  

  • 33. Deciphering Parkinson's disease--PARK8.
    Bonifati V
    Lancet Neurol; 2002 Jun; 1(2):83. PubMed ID: 12849510
    [No Abstract]   [Full Text] [Related]  

  • 34. Parkinson's disease: viral vector delivery of parkin generates model results in rats.
    Kirik D; Björklund A
    Gene Ther; 2005 May; 12(9):727-9. PubMed ID: 19202633
    [No Abstract]   [Full Text] [Related]  

  • 35. Mapping and sequencing of the human genome.
    Ruddle FH
    Jpn J Cancer Res; 1998 Dec; 89(12):inside front cover. PubMed ID: 10081483
    [No Abstract]   [Full Text] [Related]  

  • 36. Parkin and Parkinson disease.
    Shimura H; Mizuno Y; Hattori N
    Clin Chem; 2012 Aug; 58(8):1260-1. PubMed ID: 22550221
    [No Abstract]   [Full Text] [Related]  

  • 37. [Inactivation of parkin in Parkinson disease].
    Winklhofer KF
    Pharm Unserer Zeit; 2006; 35(3):186-7. PubMed ID: 16724519
    [No Abstract]   [Full Text] [Related]  

  • 38. Nature's Parkin experiment: Nix-a novel protective mechanism in Parkinson's disease.
    Olszewska DA; Lynch T
    Mov Disord; 2017 Jul; 32(7):992. PubMed ID: 28432765
    [No Abstract]   [Full Text] [Related]  

  • 39. Putting a PARKINg brake on neurodegeneration.
    Lu B
    Mol Psychiatry; 2004 Jan; 9(1):6-7. PubMed ID: 14699438
    [No Abstract]   [Full Text] [Related]  

  • 40. Synaptotagmin-11 Is a novel hotspot in the pathogenesis of parkin-linked Parkinson's disease: New implications for clinical targeting.
    Moghaddam HS; Arabi MH
    Mov Disord; 2018 Apr; 33(4):582. PubMed ID: 29573288
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.